Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516265 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Brain Tumor - Pipeline Assessment and Market Forecasts to' returned 5 results - Page 1 of 1

  Sort by   
  Sorted by Rank Top-Bottom

Molecular Diagnostics - Technologies, Markets and Companies  
Jain PharmaBiotech, May 2012, Pages: 1037
technologies, applications and geographical regions. Forecasts are made up to 2021. A major portion of the molecular diagnostic market can be attributed to advances in genomics and proteomics. Biochip and


Neuroprotection - Drugs, Markets and Companies  
Jain PharmaBiotech, May 2012, Pages: 633
known to have a neuroprotective effect. With the approval of new products and takeover of markets for obsolete symptomatic therapies, the neuroprotection market value will rise by the year 2016 when it


Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2009  
Life Science Intelligence, Inc., Dec 2009, Pages: 1763
acquires neurological signals from the brain and translates them into speech - Percutaneously delivered implantable system to treat mitral valve regurgitation and improve congestive heart failure


Emerging Medical Technologies (EMT) Database  
Life Science Intelligence, Inc., July 2007
of tumor-specific nano-particles, adaptable to all solid tumors Company 65 - Precise miniature robotic technology for spine, knee, orthopedic, and neurosurgery minimally invasive procedures


Radiation Therapy Equipment - Global Strategic Business Report  
Global Industry Analysts, Inc., Oct 2010, Pages: 360
TomoTherapy in Strategic Alliance with PTW 107 Varian and BrainLAB Collaborate to Develop Novalis®Tx 107 XCounter Enters into Commercial Partnership with


Results:  First -   Prev -   1 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds